Evans Medicine by University Hospital, Evans Memorial Department of Clinical Research and Preventive Medicine & Levinsky, Norman G.
Boston University
OpenBU http://open.bu.edu
BU Publications Evans Medicine
1987
Evans Medicine: Summer 1987 v.
3, no. 2
https://hdl.handle.net/2144/22460
Boston University
B O S T O N U N I V E R S I T Y M E D I C A L C E N T E R 
E V A N 
M E D I C I N E 
Evans Memorial Department of Clinical Research and Preventive Medicine 
th anniversary issue 
The vision of its founding benefactor 
still animates the work of the Evans 
V O L U M E 3, N U M B E R 2 
S U M M E R 1987 
By Norman G. Levinsky, M.D. 
Director, Evans Department of Medicine 
T 
he Robert Dawson Evans 
M e m o r i a l Department of 
C l in ica l Research and Pre-
ventive Medic ine—to give 
the Evans its f u l l , off icial 
name—was dedicated on 
March 6, 1912. The department was estab-
lished w i t h a gif t f r o m Mrs . Maria A n t o i -
nette Evans as a memor ia l to her husband. 
Above the entrance to the Evans Bui lding 
was inscribed the personal credo of the do-
nor: " T r u t h Above Everything. " 
She set for th , as goals of the department, 
the f o l l o w i n g : 
• To seek improved methods for the preven-
t i o n of disease and for its al leviat ion and 
cure: C l in ica l Research. 
• To aid those w h o may prove w o r t h y i n 
their efforts to secure advanced education i n 
the medical sciences: Training. 
• To furnish i n s t r u c t i o n to the public i n the 
preservation of heal th: Public Education. 
Robert Dawson Evans, a colorful and vig-
orous businessman, had risen f r o m poverty 
to riches. Son of a Canadian seaman w h o had 
been lost at sea, young Evans and his f a m i l y 
moved to Boston. He fought i n the C i v i l War 
and, having been wounded twice i n the Bat-
tle of Bul l Run, returned to his first job, at a 
local rubber store, for $10 per week. 
Building an art collection 
W i t h i n a few years Evans had risen f r o m 
employee to president of his o w n rubber 
company, and he u l t i m a t e l y became one of 
the leaders of the rubber industry i n the 
U n i t e d States. I n the 1890s, however, Evans 
gave up his interests i n rubber and turned his 
energies to the creation of an even more l u -
crative career i n gold m i n i n g , i n the state of 
California. By the t u r n of the century, he was 
an established "captain of industry , " l i v i n g 
i n splendor i n his mansion at the corner of 
C o m m o n w e a l t h Avenue and Gloucester 
Street i n Boston. There, he pursued his inter-
est i n fine art, developing a notable collec-
t i o n of paintings. O n July 1, 1909, Evans 
was t h r o w n f r o m his horse w h i l e preparing 
his N o r t h Shore summer estate for a v is i t by 
President W i l l i a m Howard Taft. By July 4, i t 
was evident that he had suffered a ruptured 
viscus. He was taken to the Massachusetts 
Homeopathic Hospital , forerunner to the 
present Univers i ty Hospital . After a rapid 
d o w n h i l l course, he died on July 6, 1909. 
The Boston Evening Transcript, the lead-
ing Boston newspaper of i ts t ime, headlined 
his obituary, "Robert D . Evans dead—He 
came to Boston a poor hoy and amassed a 
fortune of $12,000,000." 
A memorial tribute 
As a t r ibute to Evans, his widow, Maria 
Antoinet te , donated to the Massachusetts 
Homeopathic Hospita l a medical research 
bui ld ing and an endowment of $100,000 to 
m a i n t a i n the research department. 
Over the next several years she made addi-
t ional gifts, and at her death, her estate was 
divided equally between the Evans Depart-
ment of C l in ica l Research and the Boston 
M u s e u m of Fine Arts . 
When the Evans Department was estab-
lished i n 1912 i t was one of the few i n s t i t u -
tions of its k i n d i n the w o r l d . C l in ica l 
Continued on page 2 
The 75th anniversary 
celehration will fea-
ture an extensive sci-
entific program and 
varied social events. 
Page 5. 
The 
University 
Hospital 
View from early 1960s shows 1942 Evans Building, 
Visible at left is East Newton Street Armory, then 
being used as athletic building by Boston-area stu-
dents. Part of armory's site was later used for new 
Evans Building, which was completed in 1972. 
investigation was carried on i n a number of 
hospitals and research facilities, hut separate 
departments of research were rare. A t the 
t ime of the department's founding, the mod-
ern scientific revolut ion and the advance of 
American research-oriented medicine were 
just beginning. Perhaps w i t h the advice of 
Dr. Frank C. Richardson, personal physician 
to the Evans f a m i l y and first director of the 
Evans, the purposes of the department were 
formulated hy Mrs . Evans i n a remarkably 
enlightened manner that was m u c h ahead of 
its t ime . 
A strong emphasis on research 
Mrs. Evans indicated that the "laboratories 
are to he maintained for research w o r k and 
restricted to such purposes. T w o floors of the 
bui lding are to be devoted exclusively to the 
care of patients under the treatment and ob-
servation of research workers. One additional 
floor is to he used as an a u d i t o r i u m for pur-
poses pertaining to research, preventive med-
icine and public education i n the preserva-
t ion of health. The Evans Department is not 
a hospital and must not he considered f r o m 
that standpoint as are those ins t i tut ions 
whose sole f u n c t i o n is the healing of the 
sick." 
Thus, f r o m its beginnings the Evans was 
designed to foster c l in ica l research by provid-
ing facilities and support for c l inic ian-
investigators w h o w o u l d conduct laboratory 
research directed toward the solut ion of c l in-
ical problems presented by patients under 
their care. 
The department was also intended f r o m its 
origin to educate the lay public about health 
and disease. W i t h i n a few days of the open-
ing of the Evans, a series of health talks was 
in i t ia ted for the general public . From the 
start, the Evans also funct ioned as a t ra ining 
fac i l i ty for c l in ica l investigators and stu-
dents, the latter through its connection 
(physical as w e l l as administrative) w i t h Bos-
ton Univers i ty School of Medicine. 
Contrihutions hy the Evans 
Over the past 75 years, the department has 
been home to hundreds of staff, w h o have 
carried out its pr ime mission of c l inical i n -
vestigation. A number of its physician-
scientists achieved internat ional recognition 
for their research advances. Examples w h i c h 
come readily to m i n d are Chester Reefer and 
Louis Weinstein i n infectious diseases; Rob-
ert W i l k i n s i n hypertension,- Franz Ingelfin-
ger i n gastroenterology; and A r n o l d Relman 
i n nephrology. Thousands of fellows, resi-
dents and medical students, moreover, have 
trained at the Evans. 
The original Evans Building, w h i c h now 
houses administrat ive offices of the School of 
Medicine and its School of Public Health, 
was succeeded i n 1942 hy a "new Evans." I n 
1972, the "new Evans," located on East 
N e w t o n Street near Harrison Avenue, was 
succeeded by the current Evans Building. 
This fac i l i ty today houses a staff of about 80 
M . D . and Ph.D. investigators,- more than half 
the patients under the care of the Univers i ty 
Hospital Department of Medicine; and the 
50 medical residents and 50-to-60 fel lows 
w h o are i n t ra in ing at the Evans. 
Over the past 75 years, the size of the staff 
has increased severalfold. The pace and vo l -
ume of medical research at the Evans have 
reached levels undreamt of i n 1912. St i l l , the 
original goals of the Evans—to discover 
" T r u t h Above Everything" f r o m scientific re-
search i n t o the causes, treatment and pre-
vent ion of h u m a n disease; to t ra in the next 
generation of medical investigators and sci-
entif ic cl inicians; and to educate the public 
about the f rui ts of medical research—these 
purposes are as va l id i n 1987 as they were i n 
1912. 
N o better f o r m u l a t i o n of the modus oper-
andi of the Evans can he offered than that 
w h i c h Dr. W i l k i n s , previous director of the 
Evans, wrote on the occasion of the depart-
ment's 50th anniversary: 
Dr. Wilkins's statement 
" A l l of these developments denote a broad-
ening of the interests and activities of the 
Evans M e m o r i a l beyond the strict l i m i t s of 
the Hospital or of the Department of Medi -
cine, to other parts of the Medical Center. 
Whi le due precautions w i l l he taken not to 
spread the Evans's resources too t h i n , nor to 
expand its activities beyond closely manage-
able proportions, further broadening of its 
scope may he expected. This is possible only 
because of strict adherence to t w o cardinal 
principles of Evans Policy: 
Continued on page 6 
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Robert Dawson Evans 
When the Evans De-
partment was estab-
lished in 1912, it was 
one of the few insti-
tutions of its kind in 
the world. 
I 
Hypertension research, 
long an Evans tradition, 
today focuses on how 
vessels are damaged 
The history of hypertension research and 
treatment is i n t i m a t e l y hound up w i t h that 
of the Evans, especially over the depart-
ment's past four decades. 
To cite selected examples of key develop-
ments i n this area that have emerged f r o m 
the Evans: 
Robert W. W i l k i n s , M . D . , director of the 
Evans and the U H Department of Medicine 
f r o m 1960 to 1972, along w i t h his associates, 
was responsible for introducing i n the U n i t e d 
States the drug reserpine, the first effective 
anti-hypertensive medication. Dr. W i l k i n s , 
now retired and l i v i n g i n Newhuryport , 
Mass., also devised the step-care approach to 
hypertension treatment, i n w h i c h agents 
w i t h different mechanisms of action are 
comhined sequentially, as needed, i n order to 
control hypertension. 
I n 1957, Dr. W i l k i n s , W i l l i a m Hollander, 
M . D . , and A r a m V. Chohanian, M . D . , devel-
oped diuretic therapy for hypertension. This 
approach represented a major breakthrough, 
making possible the management of severe 
as w e l l as m i l d hypertension. 
The advances i n antihypertensive therapy 
have continued i n the past decade. Haramho-
los Gavras and his wife , Irene, both M.D.s 
and both members of the Evans Section of 
Hypertension and Atherosclerosis, collabo-
rated w i t h Dr. Chobanian on the develop-
ment of captopril , and subsequently enala-
p r i l . Both are angiotensin- inhihit ing 
enzymes, and they represent an excit ing d i -
rection i n therapy, providing what is now the 
most useful approach available for managing 
refractory hypertensives as w e l l as patients 
affected by congestive heart failure. 
Changing attitude toward treatment 
As these investigators and their counter-
parts at other ins t i tu t ions have been intro-
ducing an array of new treatments, medicine 
as a whole has undergone a marked change 
i n at t i tude toward hypertension therapy. 
" W h e n 1 first came here as a fe l low i n the 
late '50s, there was a very strong feeling i n 
some circles that lower ing blood pressure 
w o u l d be i n j u r i o u s , " recalls Dr. Chobanian, 
w h o heads the Evans Section of Hyperten-
sion and Atherosclerosis. 
Numerous studies, however, have since 
demonstrated that treating hypertension can 
be h ighly effective. 
The earliest studies, says Dr. Chobanian, 
showed that lower ing pressure is very benefi-
cial for individuals w i t h severe or malignant 
hypertension. " N i n e t y percent or more of 
those individuals w o u l d die w i t h i n a year 
w i t h o u t t reatment , " says the investigator, 
" b u t most of those w h o are treated medically 
survive . " 
Subsequent studies showed that therapy 
also offered important benefits for patients 
w i t h mi lder forms of hypertension, produc-
ing a marked reduction i n the incidence of 
strokes, and heart and kidney failure. 
Such findings have helped fuel widespread 
acceptance of the need for treatment. Yet 
w h i l e acceptance has grown, there is contro-
versy about some of the benefits of therapy 
for the mildest forms of hypertension, where 
the diastolic pressure is roughly between 90 
and 100. 
Coronary disease at issue 
"The big c l inical question r ight now is. 
W h y are we not getting a better reduction i n 
the incidence of coronary disease f r o m lower 
blood pressure?" says Dr. Chobanian. "We're 
preventing strokes and we're preventing 
heart failure, but most of the studies involv-
ing m i l d hypertensives indicate that we have 
only had a slight impact on coronary disease 
or overall m o r t a l i t y . " 
That concern has given new impetus to 
the basic research being pursued by Dr. 
Chobanian and his colleagues. Their inquir-
ies may help explain w h y treatment appar-
ently is not prolonging l i fe or reducing rates 
of myocardial infarc t ion i n individuals w i t h 
m i l d hypertension, and also may suggest new 
types of therapies. 
A consistent thread r u n n i n g through Dr. 
Chohanian's research interests is the mecha-
nisms by w h i c h the vessel w a l l is damaged. 
In the 1950s and 1960s, he, along w i t h Dr. 
Hol lander—now a BUSM professor of medi-
cine, biochemistry and physiology—and oth-
ers helped i l l u m i n a t e the factors that pro-
duce atherosclerotic plaques. The group 
showed that the key factors are the extent of 
penetration of cholesterol in to the arterial 
i n t i m a , metabolic activities w i t h i n arteries, 
and the effectiveness of the body's mecha-
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"When I first came 
here in the late '50s, 
there was a very 
strong feeling in 
some circles that 
lowering blood pres-
sure would be inju-
rious." 
Dr. Chobanian in his Cardiovascular Institute 
laboratory. 
Diagrams illustrate response to different types of insults. From left, they depict: 1., normal rat aorta; 2., 
aorta after six weeks exposure to elevated blood pressures, with thickened media, adherence of blood cells 
to intimal surface, and increased mitotic activity among smooth-muscle cells; and, 3., artery affected by 
both hypercholesterolemia and hypertension, with cell loss and platelet aggregation of endothelium, and 
accumulation of smooth-muscle and circulating blood cells in subendothelium. 
nisms for clearing the cholesterol once i t has 
entered the vessel w a l l . 
Studying arterial responses 
A m o n g Dr. Chohanian's chief current i n -
terests is how the artery w a l l responds to hy-
pertension. He and Peter I . Brecher, Ph.D., a 
professor of biochemistry at BUSM as w e l l as 
a member of the Evans, have helped shed 
l ight on one of the mechanisms by w h i c h 
blood pressure produces th ickening of the ar-
terial w a l l and hypertrophy of its smooth-
muscle cells. 
" F r o m w o r k that we and others have done 
i n the rat model, i t 's clear that the amount 
of D N A i n many of the arterial smooth-mus-
cle cells can double i n response to hyperten-
s ion , " says Dr. Chohanian. 
This phenomenon, called polyploidy, can 
occur w i t h i n a m o n t h of the t i m e that the 
animals ' pressures are raised, and a quarter 
or more of the smooth-muscle cells may be 
affected. "The cells seem to go into the 
g r o w t h cycle," says the investigator, " h u t for 
some reason they don't divide, so D N A 
builds up w i t h i n i n d i v i d u a l cells." 
The extent to w h i c h polyploidy is respon-
sible for the smooth-muscle hypertrophy that 
occurs i n arteries exposed to high blood pres-
sures is unclear, because smooth-muscle 
cells also become hypertrophic or hyperplas-
t ic i n the absence of D N A abnormalities. 
The findings about the D N A buildup, how-
ever, raise the possibi l i ty that genetic mal -
funct ioning may he implicated i n damage to 
arteries. 
A group w o r k i n g under Dr. Chohanian is 
exploring this possibil ity. Their specific focus 
is whether g r o w t h factors are somehow s t im-
ulated hy hypertension, and thus are partly 
to blame for the abnormal growth of cells i n 
artery walls affected by high blood pressure. 
Probing age-related damage 
Dr. Chobanian's investigations have i m p l i -
cations not only for the types of arterial hy-
pertrophy w i d e l y recognized as abnormal, 
but also for the arterial changes long re-
garded as a normal part of aging. 
The investigator says his studies related to 
the aging of vessels were st imulated i n part 
by some i n t r i g u i n g observations i n animals. 
" I f you look at the blood vessels f r o m young, 
hypertensive rats," he says, " y o u ' l l see that 
they often look v i r t u a l l y the same as vessels 
f r o m older, normotensive animals ." 
To test whether lowering pressures m i g h t 
prevent the hypertrophy and hyperplasia that 
underlies these changes. Dr. Chobanian and 
his associate Chris t ian Haudenschild, M . D . , 
a professor of pathology at BUSM, experi-
menta l ly reduced the pressures i n rats to the 
l o w normal range. The result was that arter-
ies f r o m the treated animals exhibited al-
most none of the changes normal ly associ-
ated w i t h aging. 
Does this mean that i t might be appropri-
ate to consider treating individuals w i t h pre-
sumably normal blood pressures? N o t yet, 
says Dr. Chobanian. " A t this point , we're 
really concerned w i t h the basic process that 
is going o n , " he notes. " I t w o u l d he a tre-
mendous step f r o m where we are now to he-
gin t a l k i ng about c l inical applications." 
Protecting the endothelium 
w h i l e the investigators' laboratory w o r k is 
Continued on page 6 
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"If you look at the 
blood vessels from 
young, bypertensive 
rats, you II see tbat 
they often look vir-
tually the same as 
vessels from older, 
normotensive ani-
mals." 
Cardiovascular Institute: Focal point for hypertension studies 
Since 1974, m u c h of the hypertension research at Boston Univers i ty Medical Center has 
been carried out under the auspices of the Cardiovascular Inst i tute (CVI), w h i c h was 
founded that year by Dr. A r a m Chobanian. 
N o t long after its founding, the Inst i tute was designated a Specialized Center for Research 
i n Hypertension hy the Nat ional Institutes of Health. I t is one of five such centers i n the 
country. 
East year, the Nat iona l Institutes of Health named the CVI the first—and so far the 
o n l y — N a t i o n a l Research and Demonstrat ion Center for Hypertension. As such, i t has 
responsibilit ies that include not only carrying out basic and cl inical research, hut also 
developing new systems for the control of hypertension i n the c o m m u n i t y and exploring 
nat ional health-pol icy issues related to hypertension. • 
The 75th anniversary program: Come one, come all! 
The Evans w i l l m a r k its 75th anniversary 
w i t h a scientific program and gala celebra-
t i o n on Thursday and Friday, Oct. 29 and 30. 
A l l former Evans staff, fellows, residents 
and students are i n v i t e d to participate. The 
scientific program w i l l include 12 satellite 
symposia on recent advances i n internal 
medicine on Thursday, a series of "state-of-
the-art" lectures on Friday, and the D i s t i n -
guished Basic Science Lecture by Nobel lau-
reate Walter Gilbert , M . D . , professor of mo-
lecular biology at Harvard Medical School, 
also on Friday. The program is certified for 
cont inuing medical education credit and is 
open to Evans graduates and former fellows 
w i t h o u t charge. 
There w i l l be a reception at Boston's Park 
Plaza Hote l , site of the satellite symposia, on 
Satellite Symposia, Oct. 29, 1987 
Thursday after the symposia have concluded. 
O n Friday, there w i l l he a comhined lunch-
eon and "poster session" i n the BUSM's Hie-
hert Eounge. That day's plenary lectures w i l l 
he given i n the Evans Building's Keefer A u d i -
t o r i u m . There also w i l l be opportunities to 
vis i t the Hospital 's new A t r i u m Pavilion, a 
233-hed core c l inical fac i l i ty that w i l l have 
its grand opening i n November. 
For further i n f o r m a t i o n on the satellite 
symposia, please contact: 
Office of C o n t i n u i n g Medical Education 
Boston Univers i ty School of Medicine 
80 East Concord Street 
Boston, M A 02118 
(617) 638-4605 
Fol lowing are the faculty and topics for the 
symposia and the plenary lectures: 
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(Park Plaza Hotel) 
Title 
Current Views i n Cardiology 
Advances i n Hematology/ 
Oncology 
Gastroenterology at the Evans 
Fungal Infections and A n t i f u n -
gal Therapy 
A 30-Year Perspective on Car-
diovascular Epidemiology f r o m 
the Framingham Study 
Update i n Nephrology 
Progress i n Hypertension 
Recent Progress i n Selective 
Targeting of Cancer Cells 
Recent Advances i n Endocri-
nology 
Mechanisms of Cel l Act iva-
t i o n 
Special Topics for the Practic-
ing Internist 
Sponsoring Evans Section 
Cardiology 
Hematology/Oncology 
Gastroenterology 
Infectious Diseases 
Epidemiology 
Renal 
Hypertension 
Medical Oncology/ 
Biomolecular Medicine 
Endocrinology 
Pulmonary/Immunology 
General Medicine 
Eaculty Director 
Thomas J. Ryan, M . D . 
Eewis R. Weintraub, M . D . 
Ronald P. McCaffrey, M . D . 
J. Thomas EaMont, M . D . 
Richard Diamond, M . D . 
Joseph Stokes I I I , M . D . 
N o r m a n C. Levinsky, M . D . 
A r a m V. Chohanian, M . D . 
Ronald McCaffrey, M . D . 
John R. Murphy, Ph.D. 
James C. Melhy, M . D . 
David Center, M . D . 
David I . Beller, Ph.D. 
Robert Friedman, M . D . 
State-of-the-Art Lectures, Oct. 30,1987 
(Evans Bui lding, The Univers i ty Hospital) 
• Plagues of the T w e n t i e t h Century—Eouis Weinstein, M . D . , formerly chief of the Evans 
Section of Infectious Diseases,- professor of medicine, emeritus, Harvard Medical School. 
• Contr ibut ions of the Framingham Heart Study to the Conquest of Cardiovascular Plagues— 
W i l l i a m Kannel, M . D . , chief, Evans Section of Preventive Medicine and Epidemiology; pro-
fessor of medicine, Boston Univers i ty School of Medicine. 
• Gallstones: Observe, Obliterate or Operate—Martin C. Carey, M . D . , D.Sc; formerly Evans 
fe l low i n gastroenterology; Lawrence J. Henderson Associate Professor of Heal th Sciences 
and Technology, Harvard-M.I .T. D i v i s i o n of Heal th Sciences and Technology. 
Current Research at the Evans, poster session (Hiehert Lounge, BUSM) 
• Redesigning the Diphther ia T o x i n Structural Gene: Targeted Cytotoxins for Potential Ther-
peutic Use—John R. Murphy, Ph.D., chief, Evans Section of Biomolecular Medicine; re-
search professor of medicine, Boston Univers i ty School of Medicine. 
Distinguished Basic Science Lecture. Walter Gilbert, Ph.D., professor of molecular biology. 
Harvard Univers i ty . 
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Benefactor.. 
Continued from page 2 
1. The insistence on excellence i n Evans 
personnel. 
2. The delegation of author i ty and respon-
s ib i l i ty to these h igh ly qualif ied persons for 
the development and financing (mainly 
through outside grants) of their o w n pro-
grams. 
" I n this way, Evans funds can be used to 
get new programs under way and to back 
them up i n times of emergency, hut can then 
be released to support other new activities 
that need development. 
"As always, there w i l l he insistence upon 
the principles that have contributed m u c h to 
the success of the Evans: Excellence and 
Freedom. Other than this, the location, f o r m 
and program of the Evans M e m o r i a l of the 
future w i l l he fiexihle and adaptable to the 
circumstances and needs of the future. Thus, 
the Evans Department of Cl in ica l Research 
w i l l cont inue to honor its name and to f u l f i l l 
its miss ion of service to the C o m m u n i t y and 
M a n k i n d . " 
The staff has grown, the buildings have 
been replaced by successively larger struc-
tures, but the raison d'etre of the department 
hegun by a w o m a n of foresight 75 years ago 
persists intact . • 
Hypertension... 
Continued from page 4 
s t i l l focused on hasic questions, i t is none-
theless taking directions that may eventually 
have important c l inical implicat ions . Some 
recent research, for example, has made use of 
propanolol, the heta blocker that is widely 
used to treat arrhythmias, angina and related 
conditions. 
" I n animal studies," says Dr. Chobanian, 
"we've found that w h e n you use a beta 
blocker l i k e propanolol, i t prevents the 
bui ldup of excess D N A i n response to hyper-
tension." Other studies, meanwhile , have 
shown that propanolol also prevents the for-
m a t i o n of atherosclerotic plaques i n rabbits 
on high-cholesterol diets. 
The studies support the hypothesis that 
the sympathetic nervous system's adrenergic 
pathways play a cr i t ical role i n the arterial 
wall 's response to injury. They also suggest, 
however, that other mechanisms are at w o r k 
as w e l l . One of the forms of propanolol ad-
ministered to the rabbits has l i t t l e effect on 
the beta adrenergic receptors at the relatively 
l o w doses employed. Yet i t , too, helped re-
tard plaque format ion . 
Dr. Chobanian says the effect may be re-
lated to the drug's stabil izing effects on cell 
membranes. "We t h i n k the propanolol is 
changing the permeabil i ty of the endothelial 
cells hy a local membrane effect," he ex-
plains, "so you don't get as m u c h cholesterol 
coming i n t o the ce l l . " 
Dr. Chohanian says that i n t ime, new ther-
apeutic approaches are l i k e l y to emerge f rom 
studies such as those under way i n his labo-
ratory. A l t h o u g h the nature of these ap-
proaches is not yet clear, he has some ideas 
about what directions they may take. 
"We w i l l he looking for approaches that do 
more than just lower blood pressure," he 
suggests. "That w i l l probably mean lowering 
serum cholesterol levels as wel l , for exam-
ple . " • 
Suggested further reading 
1. Chobanian, A .V. : Hypertension, antihyperten-
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